A study by Children's Medical Research Institute (CMRI) researchers reveals a new group of proteins that guide the powerful enzyme telomerase, opening potential doors to novel treatments for cancer, ...
“[…] senescence of distinct cells in the TME has different effects on cancer progression and that endothelial cell function preservation is important in ...
THIO-101 Phase 2 trial to enroll patients in the U.S. as part of the expansion of the study in third-line treatment for advanced non-small cell ...
is a first-in-class investigational telomere-targeting agent currently in clinical development to evaluate its activity in non-small cell lung cancer (NSCLC). Telomeres, along with the enzyme ...
Investigate the advancements in detecting brain tumours through TERT expression, leading to more accurate grading and ...
(GLOBE NEWSWIRE) -- (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today highlighted positive ...
(GLOBE NEWSWIRE) -- (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced that an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback